Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization
Apr
8
2024
Healthcare Preview for the Week of: April 8, 2024 [PODCAST] McDermott Will & Emery
Apr
8
2024
Healthcare Highlights from FTC’s 2024 PrivacyCon Sheppard, Mullin, Richter & Hampton LLP
Apr
8
2024
Closing the Loopholes: The Biden-Harris Administration’s Action Against “Junk Insurance” Sheppard, Mullin, Richter & Hampton LLP
Apr
5
2024
McDermottPlus Check-Up: April 5, 2024 McDermott Will & Emery
Apr
5
2024
Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act Greenberg Traurig, LLP
Apr
5
2024
CMS ISSUES ITS 2025 FINAL RULE: Aligning with the FCC, CMS Requires TPMOs to Obtain Beneficiary’s Prior Express Written Consent Prior to Sharing Personal Data with Other TPMOs – Even if “Manually” Dialing! Troutman Amin, LLP
Apr
5
2024
As Temperatures Start to Rise, OSHA Takes Steps to Implement Rules Concerning Heat Illness Prevention Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
5
2024
Anti-Kickbacks, Pro Patients: Whistleblower Exposes Oncology Practice’s Kickback Scheme Tycko & Zavareei LLP
Apr
4
2024
Washington State and Seattle Paid Sick and Safe Leave Updates Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
4
2024
Pack Rat Shareholders: Dealing with Hoarding in Cooperatives Norris McLaughlin P.A.
Apr
4
2024
HHS Health Care Cybersecurity Performance Goals: Proposed Incentives, Penalties and Compliance Standards Review Mintz
Apr
4
2024
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective Foley & Lardner LLP
Apr
4
2024
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements Greenberg Traurig, LLP
Apr
3
2024
Time to Pay Up: Doctors and Marketers Pay $1.5 Million Settlement for Medicare Referral Kickback Scheme Tycko & Zavareei LLP
Apr
3
2024
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO Mintz
Apr
3
2024
Two New Proposed Rules for Medicare Advantage Plans Expands Beneficiary Rights Norris McLaughlin P.A.
Apr
3
2024
US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation Greenberg Traurig, LLP
Apr
3
2024
Continuity in Coverage: CMS Extends the Unwinding SEP & Issues Final Rule for Medicaid and CHIP Enrollment Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
3
2024
Importance of Negotiating Assignment and Subletting Provisions in Health Care Leases Epstein Becker & Green, P.C.
Apr
3
2024
This Week in 340B: March 19 – 25, 2024 McDermott Will & Emery
Apr
3
2024
This Week in 340B: March 13 – 18, 2024 McDermott Will & Emery
Apr
3
2024
This Week in 340B: March 26 – April 1, 2024 McDermott Will & Emery
Apr
3
2024
OSH Law Primer, Part IV: The General Duty Clause Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
2
2024
Examining Community Benefit: The IRS' Shifting Standards for Tax-Exempt Hospitals Polsinelli PC
Apr
2
2024
Happy National Employee Benefits Day 2024! Jackson Lewis P.C.
Apr
2
2024
Unpacking Averages: Adverse Events for Device-Lead Combination Products Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins